Journal article
Oral valdecoxib and injected parecoxib for acute postoperative pain: a quantitative systematic review
- Abstract:
-
Background: Clinical trials suggest that cyclo-oxygenase-2 specific inhibitors (coxibs) are an effective treatment for acute postoperative pain. The aims of this systematic review were to examine the evidence for oral valdecoxib and injected parecoxib, and quantify efficacy and adverse effects. Methods: Information from randomized, double-blind studies in acute postoperative pain was sought. The area under the pain relief versus time curve over four to six hours was dichotomized using validat...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 11.1KB)
-
(Version of record, pdf, 9.1KB)
-
(Version of record, pdf, 278.3KB)
-
- Publisher copy:
- 10.1186/1471-2253-3-1
Authors
Funding
Pain Relief Trust
More from this funder
Bibliographic Details
- Publisher:
- BioMed Central Publisher's website
- Journal:
- BMC Anesthesiology Journal website
- Volume:
- 3
- Article number:
- 1
- Publication date:
- 2003-07-01
- DOI:
- ISSN:
-
1471-2253
Item Description
- Language:
- English
- Keywords:
- Subjects:
- UUID:
-
uuid:c696999f-975a-4736-af31-fa79b3e3da2d
- Local pid:
- ora:2252
- Deposit date:
- 2008-08-12
Related Items
Terms of use
- Copyright holder:
- Jodie Barden et al
- Copyright date:
- 2003
- Notes:
- Citation: Barden, J. et al. (2003). 'Oral valdecoxib and injected parecoxib for acute postoperative pain: a quantitative systematic review', BMC Anesthesiology, 3:1 [This article is available from: http://www.biomedcentral.com/1471-2253/3/1]. Copyright 2003 Barden et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record